RK

Rahul Krishna Gupta

Active Director Director DIN 08889825
DIN 08889825 First appointment Sep 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Rahul Krishna Gupta

Data last updated:

Rahul Krishna Gupta is a Director at Nordisk Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Nordisk Pharmaceuticals Private Limited reported revenue of ₹8.7 Lakh (FY 2023).

DIN 08889825
Primary Designation Director
Industry Healthcare
First Appointment 22 Sep 2020
Oldest Company Age 6 yrs
Largest company Nordisk Pharmaceuticals Private Limited · ₹8.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Sep 20202020₹8.7 Lakh (FY 2023)Active

Board colleagues of Rahul Krishna Gupta

NameDINCompanyDesignation
Ankit Krishna Gupta08889826Nordisk Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nordisk Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rahul Krishna Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Krishna Gupta

Rahul Krishna Gupta currently holds 1 directorship: Nordisk Pharmaceuticals Private Limited (Director, since 22 Sep 2020, revenue ₹8.7 Lakh (FY 2023)).

Rahul Krishna Gupta was first appointed on 22 Sep 2020 as Director at Nordisk Pharmaceuticals Private Limited.

The current boards of Rahul Krishna Gupta's companies include Ankit Krishna Gupta (Nordisk Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available